Catalyst Wire Dossier Catalyst Wire Dossier

Standard endocrine therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Standard endocrine therapy, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer [Phase 3]

See pricing